Andrew is the CEO and founder of HealthVerity, a company developing novel technologies and tools to enhance the utility, transparency, availability and cost efficiency of emerging data assets in a privacy-compliant manner. HealthVerity offers the leading platform for the discovery, licensing and linking of large-scale healthcare data, connecting data suppliers directly to customers within pharmaceutical manufacturers, healthcare providers and payers, and maximizing data utility and analytic insights. Previously, he was Senior Vice President, Healthcare Value Solutions for IMS Health. Among the organizations reporting to Andrew were IMS Health’s Health Economics and Outcomes Research Services, Real World Evidence Solutions, Payer and Provider Services, Clinical Trial Optimization Solutions, and IMS Health Government Services. In addition, he created the company’s mobile health offerings and designed their emerging genomics strategy. Prior to IMS, Andrew was the CEO of SDI Health, the recognized leader in clinical and transactional healthcare data based analytics prior to its acquisition by IMS Health in 2011. During his tenure, SDI developed and grew one of the largest linked de-identified healthcare data assets available and became the nation’s second largest pharmaceutical informatics concern with over 600 employees servicing hundreds of clients. Andrew’s track record at SDI included multiple strategic acquisitions that enabled the company to continuously drive growth and shareholder value. Andrew holds a B.A. in English from Yale University.